EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial

Giovanni Luigi De Maria iD, John P Greenwood iD, Azfar G Zaman iD, Didier Carrié, Pierre Coste iD, Marco Valgimigli iD, Miles Behan iD, Colin Berry iD, Andrejs Erglis iD, Vasileios F Panoulas iD, Eric Van Belle iD, Christian Juhl Terkelsen iD und 6 weitere

Circulation: Cardiovascular Interventions · 2024

DOI: 10.1161/circinterventions.123.013675 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2024. Verfasst von Giovanni Luigi De Maria und 17 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Heart Centre, Oxford University Hospitals NHS Trust, United Kingdom (G.L.D.M., A.P.B.). Hauptthemen laut MEDLINE: Coronary Sinus, Myocardial Infarction, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Primary percutaneous coronary intervention (pPCI) has improved clinical outcomes in patients with ST-segment-elevation myocardial infarction. However, as many as 50% of patients still have suboptimal myocardial reperfusion and experience extensive myocardial necrosis. The PiCSO-AMI-I trial (Pressure-Controlled Intermittent Coronary Sinus Occlusion-Acute Myocardial Infarction-I) evaluated whether PiCSO therapy can further reduce myocardial infarct size (IS) in patients undergoing pPCI. METHODS: Patients with anterior ST-segment–elevation myocardial infarction and Thrombolysis in Myocardial Infarction flow 0-1 were randomized at 16 European centers to PiCSO-assisted pPCI or conventional pPCI. The PiCSO Impulse Catheter (8Fr balloon-tipped catheter) was inserted via femoral venous access after antegrade flow restoration of the culprit vessel and before proceeding with stenting. The primary end point was the difference in IS (expressed as a percentage of left ventricular mass) at 5 days by cardiac magnetic resonance. Secondary end points were the extent of microvascular obstruction and intramyocardial hemorrhage at 5 days and IS at 6 months. RESULTS: Among 145 randomized patients, 72 received PiCSO-assisted pPCI and 73 conventional pPCI. No differences were observed in IS at 5 days (27.2%±12.4% versus 28.3%±11.45%; P =0.59) and 6 months (19.2%±10.1% versus 18.8%±7.7%; P =0.83), nor were differences between PiCSO-treated and control patients noted in terms of the occurrence of microvascular obstruction (67.2% versus 64.6%; P =0.85) or intramyocardial hemorrhage (55.7% versus 60%; P =0.72). The study was prematurely discontinued by the sponsor with no further clinical follow-up beyond 6 months. However, up to 6 months of PiCSO use appeared safe with no device-related adverse events. CONCLUSIONS: In this prematurely discontinued randomized trial, PiCSO therapy as an adjunct to pPCI did not reduce IS when compared with conventional pPCI in patients with anterior ST-segment–elevation myocardial infarction. PiCSO use was associated with increased procedural time and contrast but no increase in adverse events up to 6 months. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03625869.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary SinusMyocardial InfarctionST Elevation Myocardial InfarctionPercutaneous Coronary InterventionHumansCoronary CirculationTreatment OutcomeProspective StudiesHemorrhage

Stichwörter der Autor:innen

ST elevation myocardial infarctioncoronary sinuspercutaneous coronary intervention

Autor:innen und Institutionen

  • Oxford Heart Centre, Oxford University Hospitals NHS Trust, United Kingdom (G.L.D.M., A.P.B.).
  • National Institute for Health Research Oxford Biomedical Research Centre, United Kingdom (G.L.D.M., A.P.B.).
  • Leeds University and Leeds Teaching Hospitals NHS Trust, United Kingdom (J.P.G.).
  • Cardiothoracic Centre, Freeman Hospital and Newcastle University, Newcastle upon Tyne, United Kingdom (A.G.Z.).
  • CHU Rangueil, Toulouse, France (D.C.).
  • Hôpital Cardiologique du Haut Lévéque, University of Bordeaux, France (P.C.).

ORCID-Profile: Giovanni Luigi De Maria, John P Greenwood, Azfar G Zaman, Pierre Coste, Marco Valgimigli, Miles Behan, Colin Berry, Andrejs Erglis, Vasileios F Panoulas, Eric Van Belle, Christian Juhl Terkelsen, Jens Flensted Lassen, Gregg W Stone

Zitieren

APA

De Maria, G. L., Greenwood, J. P., Zaman, A. G., Carrié, D., Coste, P., Valgimigli, M., Behan, M., Berry, C., Erglis, A., Panoulas, V. F., Van Belle, E., Juhl Terkelsen, C., Hunziker Munsch, L., Jain, A. K., Lassen, J. F., Palmer, N., Stone, G. W., & Banning, A. P. (2024). Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.123.013675

Vancouver

De Maria GL, Greenwood JP, Zaman AG, Carrié D, Coste P, Valgimigli M, et al. Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial. Circulation: Cardiovascular Interventions. 2024. doi:10.1161/circinterventions.123.013675

BibTeX
@article{DeMaria2024,
  author = {De Maria, Giovanni Luigi and Greenwood, John P and Zaman, Azfar G and Carrié, Didier and Coste, Pierre and Valgimigli, Marco and Behan, Miles and Berry, Colin and Erglis, Andrejs and Panoulas, Vasileios F and Van Belle, Eric and Juhl Terkelsen, Christian and Hunziker Munsch, Lukas and Jain, Ajay K and Lassen, Jens Flensted and Palmer, Nick and Stone, Gregg W and Banning, Adrian P},
  title = {Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1161/circinterventions.123.013675}
}
Kostenlos starten →